What Researchers Did
Researchers developed and tested a hyperbaric photo-extracorporeal membrane oxygenation (ECMO) device to enhance carbon monoxide (CO) removal from CO-poisoned human blood.
What They Found
The study found that applying hyperbaric oxygen to the photo-ECMO device significantly increased the rate of CO elimination from human blood. This is particularly relevant as CO poisoning leads to nearly 50,000 emergency department visits and 1200 deaths annually, with CO having a 250-fold higher affinity for hemoglobin than oxygen.
What This Means for Canadian Patients
This technology could offer a more accessible and efficient treatment for carbon monoxide poisoning, especially in areas without immediate access to hyperbaric chambers. It could potentially reduce treatment delays and improve outcomes for patients suffering from CO toxicity.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The research was conducted using human blood samples in a laboratory setting, indicating a need for further in vivo studies to validate these findings in living organisms.